Literature DB >> 792333

Specific lysis of human colon tumor cells by antibodies to CEA and isoantigen A: dependence on rabbit serum or neuraminidase.

W A Tompkins, P B Seth, D M Yip, J L Palmer, S R Gee, W E Rawls.   

Abstract

The 51Cr cytotoxicity test was used to measure specific antibody reactions against carcinoembryonic antigen (CEA) and isoantigen A on the surface of human colon tumor cells. When human serum or guinea pig serum was used as a source of complement, no anti-CEA or anti-isoantigen A cytotoxicity was demonstrable despite binding of specific antibodies and activation of complement at least through the C3 component on the cell surface. In contrast, specific anti-CEA and anti-isoantigen A cytotoxicity was demonstrated when rabbit serum was used as a source of complement. Specific antibody-mediated cell lysis was also achieved with guinea pig complement if the cells were treated with neuraminidase before testing. These results support the concept that certain tumor cells have surface properties that render them resistant to immune lysis.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 792333

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  2 in total

1.  Non-human primate (baboon) anti-carcinoembryonic antigen antibody infusion in patients with metastatic adenocarcinoma. A phase I study.

Authors:  M S Huberman; J J Lokich; T Hill; A Kaldany; A Kassis; T Price; C Moore; S Davis; P Kasulis; A P Monaco
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

2.  Oncofoetal antigen I: a target for immune cytolysis of human cancer.

Authors:  N Sidell; R F Irie; D L Morton
Journal:  Br J Cancer       Date:  1979-12       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.